51 related articles for article (PubMed ID: 32373947)
1. MicroRNA-489 targets XIAP to inhibit the biological progression of ovarian cancer via regulating PI3K/Akt signaling pathway and epithelial-to-mesenchymal transition.
Jiang HW; Li L; Jiang P; Wang YF
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4113-4122. PubMed ID: 32373947
[TBL] [Abstract][Full Text] [Related]
2. m6A-modified circASXL1 promotes proliferation and migration of ovarian cancer through the miR-320d/RACGAP1 axis.
Tian Q; Mu Q; Liu S; Huang K; Tang Y; Zhang P; Zhao J; Shu C
Carcinogenesis; 2023 Dec; 44(12):859-870. PubMed ID: 37738681
[TBL] [Abstract][Full Text] [Related]
3. MiR-185-3p regulates epithelial mesenchymal transition via PI3K/Akt signaling pathway by targeting cathepsin D in gastric cancer cells.
Huang C; Wu YJ; He WF; Zhao SL; Ouyang YY; Ai XH; Liu ZQ; Tang SY
Transl Cancer Res; 2020 Nov; 9(11):6988-7000. PubMed ID: 35117305
[TBL] [Abstract][Full Text] [Related]
4. CUDC-907 exhibits potent antitumor effects against ovarian cancer through multiple in vivo and in vitro mechanisms.
Wang Y; Wen J; Sun X; Sun Y; Liu Y; Cheng X; Wu W; Liu Q; Ren F
Cancer Chemother Pharmacol; 2024 Apr; 93(4):295-306. PubMed ID: 37938423
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-122 Is More Effective than Rapamycin in Inhibition of Epithelial-mesenchymal Transition and mTOR Signaling Pathway in Triple Negative Breast Cancer.
Ghalavand M; Dorostkar R; Borna H; Mohammadi-Yeganeh S; Hashemi SM
Iran J Allergy Asthma Immunol; 2023 Feb; 22(1):46-61. PubMed ID: 37002630
[TBL] [Abstract][Full Text] [Related]
6. Establishment of canine mammary gland tumor cell lines harboring PI3K/Akt activation as a therapeutic target.
Park SY; Baek YB; Lee CH; Kim HJ; Kim HP; Jeon YJ; Song JE; Jung SB; Kim HJ; Moon KS; Park SI; Lee CM; Kim SH
BMC Vet Res; 2024 May; 20(1):233. PubMed ID: 38807154
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-19b promotes the migration and invasion of ovarian cancer cells by inhibiting the PTEN/AKT signaling pathway.
Liu DT; Yao HR; Li YY; Song YY; Su MY
Oncol Lett; 2018 Jul; 16(1):559-565. PubMed ID: 29963131
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of miR-614 promotes proliferation and inhibits apoptosis in ovarian cancer by suppressing PPP2R2A expression.
Zhang J; Gao D; Zhang H
Mol Med Rep; 2018 May; 17(5):6285-6292. PubMed ID: 29532877
[TBL] [Abstract][Full Text] [Related]
9. TOP2A modulates signaling via the AKT/mTOR pathway to promote ovarian cancer cell proliferation.
Zhang K; Zheng X; Sun Y; Feng X; Wu X; Liu W; Gao C; Yan Y; Tian W; Wang Y
Cancer Biol Ther; 2024 Dec; 25(1):2325126. PubMed ID: 38445610
[TBL] [Abstract][Full Text] [Related]
10. LRP8 promotes tumorigenesis in ovarian cancer through inhibiting p53 signaling.
Xu Y; Zhou Y; Yi X; Nie X
Cell Biol Int; 2024 May; 48(5):626-637. PubMed ID: 38263609
[TBL] [Abstract][Full Text] [Related]
11. The antitumor effect of miR-448 in epithelial ovarian cancer.
Li T; Yuan J; Lai Y; Yu L
Transl Cancer Res; 2020 Aug; 9(8):4922-4930. PubMed ID: 35117854
[TBL] [Abstract][Full Text] [Related]
12.
Ren L; Li Y; Feng Y; Zhang Z; Yang H; Li M
Transl Cancer Res; 2024 Mar; 13(3):1443-1457. PubMed ID: 38617512
[TBL] [Abstract][Full Text] [Related]
13. XTP8 Promotes Ovarian Cancer Progression by Activating AKT/AMPK/mTOR Pathway to Regulate EMT.
Zhao R; Ning X; Lu H; Xu W; Ma J; Cheng J; Ma R
Cell Biochem Biophys; 2024 Mar; ():. PubMed ID: 38717641
[TBL] [Abstract][Full Text] [Related]
14. Low PDE4A expression promoted the progression of ovarian cancer by inducing Snail nuclear translocation.
Wang J; Gu Q; Liu Y; Huang X; Zhang J; Liu B; Li R; Linghu H
Exp Cell Res; 2024 May; ():114100. PubMed ID: 38797258
[TBL] [Abstract][Full Text] [Related]
15. Functional implications of PABPC1 in the development of ovarian cancer.
Feng C; Han YH; Qi N; Li J; Sheng QH; Liu Y; Yang LL
Open Med (Wars); 2021; 16(1):805-815. PubMed ID: 34027108
[TBL] [Abstract][Full Text] [Related]
16. Beneficial action of cinnamic acid against ovarian cancer via network pharmacology analysis and the pharmacological activity assessment.
Fan R; Liang Z; Wang Q; Chen S; Huang S; Liu J; Huang R; Chen J; Zhao F; Huang W
Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):2987-2994. PubMed ID: 37870582
[TBL] [Abstract][Full Text] [Related]
17. LINK-A: unveiling its functional role and clinical significance in human tumors.
Liao B; Wang J; Xie Y; Luo H; Min J
Front Cell Dev Biol; 2024; 12():1354726. PubMed ID: 38645412
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs, long non-coding RNAs, and circular RNAs and gynecological cancers: focus on metastasis.
Rezaee A; Ahmadpour S; Jafari A; Aghili S; Zadeh SST; Rajabi A; Raisi A; Hamblin MR; Mahjoubin-Tehran M; Derakhshan M
Front Oncol; 2023; 13():1215194. PubMed ID: 37854681
[TBL] [Abstract][Full Text] [Related]
19. Effect of miR-27b on the proliferation and apoptosis of diffuse large b-cell lymphoma cells by targeting the regulation of MET/PI3K/AKT pathway.
Zhang R; Huang T; Li J; Zhou H; Wang X
Discov Oncol; 2022 Dec; 13(1):137. PubMed ID: 36502446
[TBL] [Abstract][Full Text] [Related]
20. The Role of Cancer-Associated Fibroblasts in Ovarian Cancer.
Zhang M; Chen Z; Wang Y; Zhao H; Du Y
Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
